![Dominic F. Labriola](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dominic F. Labriola
Corporate Officer/Principal chez MADRIGAL PHARMACEUTICALS, INC.
Postes actifs de Dominic F. Labriola
Sociétés | Poste | Début | Fin |
---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 10/01/2022 | - |
Clinical Data Interchange Standards Consortium, Inc.
![]() Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 10/01/2023 | - |
Historique de carrière de Dominic F. Labriola
Formation de Dominic F. Labriola
University of Delaware | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Clinical Data Interchange Standards Consortium, Inc.
![]() Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
- Bourse
- Insiders
- Dominic F. Labriola
- Expérience